אקריזקס
trupharm marketing 1985 ltd. - dermatophagoides farina; dermatophagoides pteronyssinus - טבליה - dermatophagoides pteronyssinus 6 sq-hdm; dermatophagoides farina 6 sq-hdm - house dust
פלודרבין אבווה 50 מג2 מל
novartis israel ltd - fludarabine phosphate - תרכיז להכנת תמיסה לאינפוזיה\הזרקה - fludarabine phosphate 50 mg/dose - fludarabine - fludarabine - palliative treatment of patients with cll refractory to other therapy. treatment of less malignant non-hodgkin lymphoma of stage 3 to 4 in patients who have not responded to standard therapy with at least one alkylating agent or in whom the disease progressed during or after standard therapy. fludarabine is indicated for the initial treatment of patients with b- cell chronic lymphocytic leukaemia (cll) or after first line therapy, in patients with sufficient bone marrow reserves.
איופידין % 0.5
novartis israel ltd - apraclonidine as hydrochloride - תמיסה לעין - apraclonidine as hydrochloride 5 mg/ml - apraclonidine - apraclonidine - short term adjunctive therapy in patients on maximally tolerated medical therapy who require additional itraocular pressure reduction.
אקנתרים
trima israel pharmaceutical products maabarot ltd - erythromycin - תמיסה - erythromycin 2 %w/v - erythromycin - erythromycin - as a topical antibiotic treatment for all forms of acne, particularly inflamatory acne with papules and pustules.
the self adjustable file (saf)
רידנט-נובה בע"מ - רופא שיניים - the self adjusting file (saf) is a mechanically operated endodontic file to be used for cleaning and shaping of root canals , as part of procedure of root canal treatment
קימריה
novartis israel ltd - tisagenlecleucel - tisagenlecleucel
דוצטקסל אבווה 10 מג 1 מל
novartis israel ltd - docetaxel - תרכיז להכנת תמיסה לאינפוזיה - docetaxel 10 mg / 1 ml - docetaxel - docetaxel - breast cancer: docetaxel in combination with doxorubicin and cyclophosphamide is indicated for the adjuvant treatment of patients with operable node- positive breast cancer. docetaxel in combination with doxorubicin is indicated for the treatment of patients with locally advanced or metastatic breast cancer who have not previously received cytotoxic therapy for this condition. docetaxel monotherapy is indicated for the treatment of patients with metastatic breast cancer after failure of cytotoxic therapy. previous chemotherapy should have included an anthracycline or an alkylating agent. docetaxel in combination with trastuzumab is indicated for the treatment of patients with metastatic breast cancer whose tumors overexpress her2 and who previously have not received chemotherapy for metastatic disease. docetaxel in combination with capecitabine is indicated for the treatment of patients with metastatic breast cancer after failure of cytotoxic chemotherapy. previous therapy should have included an anthracyclin
דוסטאקסל הוספירה 10 מגמל
pfizer pfe pharmaceuticals israel ltd - docetaxel - תמיסה לאינפוזיה - docetaxel 10 mg / 1 ml - docetaxel - docetaxel - breast cancer: docetaxel in combination with doxorubicin and cyclophosphamide is indicated for the adjuvant treatment of patients with operable node- positive breast cancer. docetaxel in combination with doxorubicin is indicated for the treatment of patients with locally advanced or metastatic breast cancer who have not previously received cytotoxic therapy for this condition. docetaxel monotherapy is indicated for the treatment of patients with metastatic breast cancer after failure of cytotoxic therapy. previous chemotherapy should have included an anthracycline or an alkylating agent. docetaxel in combination with trastuzumab is indicated for the treatment of patients with metastatic breast cancer whose tumors overexpress her2 and who previously have not received chemotherapy for metastatic disease. docetaxel in combination with capecitabine is indicated for the treatment of patients with metastatic breast cancer after failure of cytotoxic chemotherapy. previous therapy should have included an anthracyclin
אבאמיס
glaxo smith kline (israel) ltd - fluticasone furoate - ספריי - fluticasone furoate 27.5 mcg/dose - fluticasone furoate - fluticasone - avamys (fluticasone furoate) nasal spray is indicated for the treatment of the symptoms of seasonal and perennial allergic rhinitis in patients aged 2 years and older.
זולאייר 150 מג
novartis israel ltd - omalizumab - אבקה וממס להכנת תמיסה להזרקה - omalizumab 150 mg/dose - omalizumab - omalizumab - xolair is indicated for adults and adolescents (12 years of age and above) with moderate to severe persistent asthma who have a positive skin test or in vitro reactivity to a perennial aeroallergen and whose symptoms are inadequately controlled with inhaled corticosteroids. xolair has been shown to decrease the incidence of asthma exacerbations in these patients. safety and efficacy have not been established in other allergic conditions.